Alaunos Therapeutics | ZIOP - Créanciers Commerciaux





Créanciers Commerciaux Changement Date
Alaunos Therapeutics USD 400K 213K 2026-03
Amgen USD 19.52B 1.37B 2026-03
AstraZeneca USD 22.51B 2.78B 2026-03
Baxter International USD 1.09B 87M 2026-03
Biogen USD 358.5M 73.5M 2026-03
Bioline Rx USD 5.66M 2.2M 2025-09
Bristol-Myers Squibb USD 4.23B 659M 2026-03
Celltrion KRW 78.68B 25.51B 2025-12
Corcept Therapeutics USD 33.31M 7.14M 2026-03
Cspc Pharmaceutical CNY 2.32B 236.83M 2025-12
Curis USD 5.61M 1.52M 2025-12
Deva Holding AS TRY 809.81M 105.88M 2023-09
Dianthus Therapeutics USD 5.27M 4.45M 2026-03
Divis Laboratories Ltd INR 10.4B 1.3B 2025-09
Gilead Sciences USD 645M 70M 2026-03
GlaxoSmithKline GBP 14.34B 1.05B 2026-03
Incyte USD 228.62M 1.41B 2026-03
Intrexon USD 4.85M 3.12M 2024-06
Ionis Pharmaceuticals USD 26.03M 2.05M 2026-03
J&J USD 10.46B 1.53B 2026-03
Kangmei Pharma CNY 2.61B 176.42M 2025-09
Karyopharm Therapeutics USD 4M 1.39M 2025-12
Knight Therapeutics CAD 125.76M 7.63M 2025-12
Laboratorios Farma EUR 107.59M 341K 2023-12
Malin Corporation EUR 700K 200K 2024-12
Medical Developments International AUD 4.31M 2.18M 2025-12
Merck USD 3.86B 541M 2026-03
Neuren Pharmaceuticals AUD 2.4M 4.26M 2025-12
Novartis USD 4.32B 134M 2026-03
Organigram Holdings CAD 71.08M 18.17M 2025-12
Ovoca Bio EUR 186K 23K 2025-06
Pfizer USD 4.51B 734M 2026-03
Pharma Mar EUR 43.83M 10.51M 2026-03
PTC Therapeutics USD 25.48M 20M 2026-03
Qiagen NV USD 72.66M 2.11M 2025-12
Regeneron Pharmaceuticals USD 1.03B 4.81B 2026-03
Roche Holding CHF 5.78B 1.27B 2025-12
Sangamo BioSciences USD 10.74M 7.46M 2025-06
Sartorius EUR 345.3M 2.2M 2026-03
Sino Biopharmaceutical CNY 2.82B 1.32B 2025-06
TG Therapeutics USD 148.84M 41.34M 2026-03
Tilray USD 114.5M 3.69M 2025-09
Verastem USD 12.45M 2.56M 2025-12
Zealand Pharma A/S 346.6M 102.71M 2025-12
Zz Pientze Pharmaceu CNY 457.05M 59.09M 2026-03